Galecto Biotech AB

2200 Copenhagen

Patents

1,1'-SULFANEDIYL-DI-BETA-D-GALACTOPYRANOSIDE ALS INHIBITOREN VON GALECTINEN

EP3374368

filed Nov 8, 2016
ALPHA-D-GALACTOSIDINHIBITOREN VON GALECTINEN

EP3250581

filed Jan 28, 2016
POLYMORPHE FORMEN VON TD139 UND VERFAHREN ZUR HERSTELLUNG

EP3390423

Deleted
NEUARTIGER GALACTOSIDINHIBITOR AUS GALECTINEN

EP3245216

Deleted
NEUARTIGER HYBRIDER GALACTOSIDHEMMER AUS GALECTINEN

EP3166956

Deleted
EINMAL TÄGLICHE BEHANDLUNG VON LUNGENFIBROSE

EP3294293

Deleted
GALAKTOSID-INHIBITOR DES GALECTIN-3 UND DESSEN VERWENDUNG ZUR BEHANDLUNG PULMONARER FIBROSE

EP2914269

Deleted
NEUARTIGE GALACTOSIDINHIBITOREN VON GALECTINEN

EP2807176

Deleted
NEUARTIGE GALECTIN-GALACTOSIDHEMMER

EP2424873

Deleted
NEUE SYNTHESE VON GALACTOSIDINHIBITOREN

EP2297174

Deleted
More trademarks (1)
Di-(3-desoxy-3-1H-1,2,3-triazol-1-yl)-beta-D-galacto-pyranosyl)sulfan Derivate als Galectin-3-Inhibitoren

EP2679595

Deleted

Holder of 11 patents, 2 in force.

From Swissreg, the register of the Federal Institute of Intellectual Property: Swiss patents and European patents with effect in Switzerland. A patent is listed here when its holder’s name is this entity’s.